X. Wan, Y. Zeng, M. Xiong, L. Chen, and Y. Bai, “FCGBP inhibits the development of LSCC and cisplatin resistance through the PIGR/JAK2/STAT3 pathway”, Radiol Oncol, vol. 60, no. 1, pp. 67–75, Mar. 2026.